Ready to play
Ready to play
A recent study has shown that patients consuming sugar during antibiotic treatment worsens gut bacterial imbalance and leads to a greater loss of microbiome diversity, with an increased likelihood of dominance by harmful bacterial strains such as Enterococcus faecium, which may cause antibiotic-resistant infections. The findings also confirmed that the consumption of sweets and added sugars, especially sugary drinks, raises the risk of disrupting the intestinal bacterial balance. This links high sugar intake to poorer health outcomes, including a higher likelihood of mortality, particularly when sugar consumption exceeds average levels during treatment. The study emphasizes the importance of reducing sugar intake while on antibiotics to preserve gut bacterial diversity and minimize health complications.
Notice: This Is an AI-Generated Summary
Comments (0)